Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Monocytes might be linked to hair loss after COVID-19.

Testosterone's effects on COVID-19 are unclear and need more research.

COVID-19 infection is highly related to increased hair loss, especially in women.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

Combining amino acid and stem cell therapy may help manage hepatocutaneous syndrome in dogs.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

COVID-19 may harm male fertility and damage the reproductive system.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.